GLP-1 receptor agonists are potent insulin sensitizers, explains Sonia Gibson, MD, a board-certified physician in endocrinology, diabetes, and metabolism, and the endocrinology physician lead at Allara Health
Cyanocobalamin Drugs (BNF)
Furthermore, they demonstrated clinically relevant benefits, including a reduced requirement for exogenous pulmonary surfactant (both in the number of infants needing treatment and the total dose administered) and a shortened duration of mechanical ventilation compared to the placebo group (73)
Undereating Protein Because appetite is significantly reduced, many people assume they are eating enough when they are not meeting protein needs
The peptide is naturally produced by the body, which suggests a favorable safety profile, but exogenous administration at supraphysiological doses may carry unknown risks